DrugPolicy / Regulatory

Zhejiang Suspends Generic Nesina Trading Due to IP Disputes

Policy / Regulatory

China’s 2022 Western Medicine Trade Analysis: Growth and Challenges

CompanyDrug

Wuhan Binhui’s Oncolytic Virus Therapy Awarded Breakthrough Designation by CDE

CompanyDrug

CDE Awards Priority Review to Eisai’s Lecanemab for Early Alzheimer’s Disease

CompanyDeals

Chunlizhengda to Acquire Majority Stake in Surgimaster for Medical Power Tools

CompanyDeals

Duoning Biotech Secures Global Rights to Junzhen’s Cell Counter Products

CompanyDeals

Sansure Biotech Partners with Hunan Normal University for Research and Talent Development

CompanyDeals

Amcor Acquires Shanghai-Based MDK to Expand Asia-Pacific Footprint

CompanyDrug

CSPC’s NBL-020 Gets NMPA Approval for Clinical Study in Advanced Solid Tumors

CompanyDrug

Kelun Pharma’s Generic Jardiance Gains New Indication in China

Policy / Regulatory

Hangzhou Singclean Stripped of VBP Status for Artificial Lenses

CompanyDeals

Topgen Biopharm Partners with Fudan University for Breast Cancer Gene Detection